Article Text

PDF

Drug Treatment of Experimental Silicosis
  1. Dinah M. James*,
  2. T. G. Morris,
  3. J. Marks
  1. Department of Pharmacology, Welsh National School of Medicine, the Pneumoconiosis Research Unit, Cardiff
  2. The Central Tuberculosis Laboratory, Cardiff

    Abstract

    It has already been shown that tissue cultures of phagocytic cells may be protected against the toxic effect of silica dust by a number of organic bases and aluminium complexes. These compounds have now been used to treat mice after the administration of silica dust intravenously. Protective activity was measured by capacity to inhibit or retard the development of silicotic nodules in the livers of the experimental animals. Drugs active in this respect were an aluminiumdextran complex, phenazine B749, methylene blue, and compound 46-107. Compound 46-107 is related chemically to compound 48-80, the subject of a previous study of protective action, but lacks the latter drug's disruptive effect on mast cells.

    Statistics from Altmetric.com

    Footnotes

    • * Present address: Department of Pharmacology, University College, Ibadan, Nigeria.

    • Now at the Tuberculosis Reference Laboratory, Public Health Laboratory Service.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.